Real-world efficacy and safety data of immune checkpoint inhibitors in

dc.contributor.author	Ozgun, MA
dc.contributor.author	Dogan, I
dc.contributor.author	Eryilmaz, MK
dc.contributor.author	Erdogan, AP
dc.contributor.author	Ayhan, M
dc.contributor.author	Hafizoglu, E
dc.contributor.author	Tolunay, PK
dc.contributor.author	Cavdar, E
dc.contributor.author	Cevik, GT
dc.contributor.author	Demir, H
dc.contributor.author	Dulgar, O
dc.contributor.author	Yilmaz, B
dc.contributor.author	Cakir, E
dc.contributor.author	Gokyer, A
dc.contributor.author	Unal, OU
dc.contributor.author	Perkin, P
dc.contributor.author	Sakalar, T
dc.contributor.author	Gulmez, A
dc.contributor.author	Tasci, ES
dc.contributor.author	Lacin, S
dc.date.accessioned	2022-10-11T12:55:20Z
dc.date.available	2022-10-11T12:55:20Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/11616/74837
dc.source	ANNALS OF ONCOLOGY
dc.title	Real-world efficacy and safety data of immune checkpoint inhibitors in
dc.title	Turkish patients with metastatic melanoma: A Turkish oncology group
dc.title	study

Files in this item

Files	Size	Format	View
There are no files associated with this item.